Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Seres Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
MCRB
Nasdaq
8731
https://www.serestherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Seres Therapeutics Inc
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
- Apr 9th, 2024 11:00 am
Increases to Seres Therapeutics, Inc.'s (NASDAQ:MCRB) CEO Compensation Might Cool off for now
- Mar 28th, 2024 4:47 pm
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mar 28th, 2024 11:00 am
11 Oversold NASDAQ Stocks To Buy Right Now
- Mar 13th, 2024 7:32 pm
11 Oversold Healthcare Stocks To Buy Right Now
- Mar 13th, 2024 12:17 pm
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript
- Mar 7th, 2024 4:48 pm
Q4 2023 Seres Therapeutics Inc Earnings Call
- Mar 6th, 2024 7:17 am
Seres Therapeutics Inc (MCRB) Reports Encouraging Sales Growth and Strategic Cost Savings in 2023
- Mar 5th, 2024 12:32 pm
Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
- Mar 5th, 2024 12:00 pm
Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024
- Feb 28th, 2024 12:00 pm
Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
- Feb 27th, 2024 12:00 pm
Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz
- Feb 26th, 2024 12:00 pm
Halozyme Therapeutics (HALO) Surges 5.6%: Is This an Indication of Further Gains?
- Jan 17th, 2024 9:01 am
Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155
- Jan 9th, 2024 12:00 pm
Seres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 4th, 2024 9:00 pm
Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023
- Dec 8th, 2023 12:46 am
Seres Therapeutics, Inc. (NASDAQ:MCRB) is a favorite amongst institutional investors who own 62%
- Dec 2nd, 2023 1:54 pm
Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
- Nov 28th, 2023 2:18 pm
Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
- Nov 21st, 2023 11:00 am
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript
- Nov 5th, 2023 7:22 pm
Scroll